Status:
TERMINATED
Risk and Benefit Informed MTM Pharmacist Intervention in Heart Failure
Lead Sponsor:
Geisinger Clinic
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Out-of-hospital care of complex diseases, such as heart failure, is transitioning from an individual patient-doctor relationship to population health management strategies. As an example, at our insti...
Detailed Description
Heart failure is a highly prevalent, complex disease associated with significant morbidity and cost. For example, Geisinger manages over 900 heart failure admissions per year, with each admission cost...
Eligibility Criteria
Inclusion
- All adult Geisinger patients with heart failure, as identified by a validated EHR (Electonic Health Record)-based phenotype algorithm,
- Patients with a Geisinger primary care provider (PCP)
- Patients who follow with Geisinger Cardiology (at least 1 visit in past two years).
- Fulfills the specifications for arm assignment based on the results of the care gap benefit model.
Exclusion
- Patients with a Geisinger PCP or Cardiologist in the South Central Region (part of the Geisinger Holy Spirit footprint) as MTM availability is limited in this service area.
- Patients who have indicated they do not wish to participate in research studies
Key Trial Info
Start Date :
February 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03804606
Start Date
February 28 2019
End Date
September 1 2023
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger Health System
Danville, Pennsylvania, United States, 17822